Successful treatment of severe retroauricular pyoderma gangrenosum with upadacitinib in a patient with Crohn’s disease and a history of cerebral venous sinus thrombosis (2026) Fousekis F, Ronicke M, Sollfrank L, Rech J, Berking C, Neurath MF, Sticherling M, Atreya R Journal article Efficacy and health-related quality of life associated with second-line vedolizumab after first-line treatment with one anti-TNF in patients with ulcerative colitis: a meta-analysis of the GEMINI-1 and VISIBLE-1 trials (2026) Atreya R, Kirchgesner J, Cheah Z, Biedermann P, Bakker L, Meyer M, Raine T Journal article JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel disease (2025) Fousekis FS, Jefremow A, Katsanos KH, Neurath M, Atreya R Journal article, Review article Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis (2025) Ferrante M, Peyrin-Biroulet L, Arkkila P, Armuzzi A, Colombel JF, Danese S, Faggiani R, et al. Journal article Risk factors associated with complications of palliative drainage of ascites with tunneled peritoneal catheters (2025) Machnik D, Fischer S, Vetter M, Lamprecht-Bailer R, Rouse-Merkel R, Klett D, Neurath M, et al. Journal article Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study (2024) Fischer S, Donhauser M, Cohnen SE, Fietkau K, Vetter M, Grübel-Liehr M, Dietrich P, et al. Journal article Treatment trajectories and outcomes in inflammatory bowel disease: a tertiary single-centre experience (2024) Wagner K, Müller T, Vitali F, Fischer S, Haberkamp S, Rouse-Merkel R, Atreya R, et al. Journal article Long-term outcomes of cyclosporin induction and ustekinumab maintenance combination therapy in patients with steroid-refractory acute severe ulcerative colitis (2024) Vitali F, Rath T, Klenske E, Vögele AL, Ganzleben I, Zundler S, Strobel D, et al. Journal article Vedolizumab blocks alpha 4 beta 7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis (2022) Besendorf L, Müller T, Geppert CI, Schneider I, Mühl L, Atreya I, Vitali F, et al. Journal article α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis (2021) Melde M, Müller T, Schneider IHF, Geppert CI, Mühl L, Besendorf L, Allner C, et al. Journal article